Comparison of an aggressive (U.S.) and a less aggressive (Canadian) policy for cholesterol screening and treatment.

PubWeight™: 2.61‹?› | Rank: Top 1%

🔗 View Article (PMID 1854109)

Published in Ann Intern Med on August 15, 1991

Authors

M Krahn1, C D Naylor, A S Basinski, A S Detsky

Author Affiliations

1: University of Toronto, Toronto Hospital, Ontario.

Articles by these authors

Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med (1998) 11.14

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ (1992) 10.40

Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med (1999) 7.68

Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med (1994) 6.78

Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA (2000) 5.94

Users' Guides to the Medical Literature: XXV. Evidence-based medicine: principles for applying the Users' Guides to patient care. Evidence-Based Medicine Working Group. JAMA (2000) 5.91

Screening for prostate cancer. A decision analytic view. JAMA (1994) 5.83

Meta-analysis in clinical research. Ann Intern Med (1987) 5.16

Users' guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group. JAMA (1997) 5.07

Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol (1992) 4.86

Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med (1997) 4.84

How should health status measures be assessed? Cautionary notes on procrustean frameworks. J Clin Epidemiol (1992) 4.54

Shopping around for hospital services: a comparison of the United States and Canada. JAMA (1998) 4.41

What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr (1987) 4.21

Meta-analysis and the meta-epidemiology of clinical research. BMJ (1997) 4.07

Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. JAMA (1998) 3.96

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med (1995) 3.69

Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med (1993) 3.53

Screening for colon cancer--can we afford colonoscopy? N Engl J Med (2001) 3.48

Communicating the benefits of chronic preventive therapy: does the format of efficacy data determine patients' acceptance of treatment? Med Decis Making (1995) 3.21

Direct and indirect costs of asthma in Canada, 1990. CMAJ (1996) 3.07

Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol (1995) 3.05

Multicenter validation of a risk index for mortality, intensive care unit stay, and overall hospital length of stay after cardiac surgery. Steering Committee of the Provincial Adult Cardiac Care Network of Ontario. Circulation (1995) 3.02

Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology (1989) 2.88

Nutritional assessment: a comparison of clinical judgement and objective measurements. N Engl J Med (1982) 2.74

Variation in breast cancer surgery in Ontario. CMAJ (1994) 2.70

Ready-made, recalibrated, or Remodeled? Issues in the use of risk indexes for assessing mortality after coronary artery bypass graft surgery. Circulation (1999) 2.67

Multicentre trial to introduce the Ottawa ankle rules for use of radiography in acute ankle injuries. Multicentre Ankle Rule Study Group. BMJ (1995) 2.50

Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA (2001) 2.49

Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries. CMAJ (1997) 2.46

Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease. J Gen Intern Med (2000) 2.21

Reflections on a month in the life of the Ontario Drug Benefit Plan. CMAJ (1994) 2.20

Nonionic contrast media: economic analysis and health policy development. CMAJ (1989) 2.13

Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med (1986) 2.13

When was a "negative" clinical trial big enough? How many patients you needed depends on what you found. Arch Intern Med (1985) 2.11

A randomized crossover trial of Quick Medical Reference (QMR) as a teaching tool for medical interns. J Gen Intern Med (1994) 2.10

Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison. J Am Coll Cardiol (1996) 2.09

Users' guides to the medical literature. VII. How to use a clinical decision analysis. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA (1995) 2.09

Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index. Arch Intern Med (1986) 2.08

Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med (1995) 2.07

Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996. CMAJ (1999) 2.04

Cost and health implications of cholesterol lowering. Circulation (1992) 2.00

What is appropriate care? N Engl J Med (1998) 1.97

Users' guides to the medical literature. VII. How to use a clinical decision analysis. B. What are the results and will they help me in caring for my patients? Evidence Based Medicine Working Group. JAMA (1995) 1.94

Diagnostic accuracy and short-term surgical outcomes in cases of suspected acute appendicitis. CMAJ (1995) 1.91

Analysis of deaths while waiting for cardiac surgery among 29,293 consecutive patients in Ontario, Canada. The Steering Committee of the Cardiac Care Network of Ontario. Heart (1998) 1.91

Coronary artery bypass graft surgery in Ontario and New York State: which rate is right? Steering Committee of the Cardiac Care Network of Ontario. Ann Intern Med (1997) 1.89

False-positive coding for acute myocardial infarction on hospital discharge records: chart audit results from a tertiary centre. Can J Cardiol (1990) 1.87

Primer on medical decision analysis: Part 3--Estimating probabilities and utilities. Med Decis Making (1997) 1.84

Fairness in the coronary angiography queue. CMAJ (1999) 1.83

Prognosis, survival, and the expenditure of hospital resources for patients in an intensive-care unit. N Engl J Med (1981) 1.72

Long-term MI outcomes at hospitals with or without on-site revascularization. JAMA (2001) 1.66

A survey of provider experiences and perceptions of preferential access to cardiovascular care in Ontario, Canada. Ann Intern Med (1998) 1.66

Perioperative parenteral nutrition: a meta-analysis. Ann Intern Med (1987) 1.62

Direct costs of coronary artery bypass grafting in patients aged 65 years or more and those under age 65. CMAJ (1999) 1.61

Coronary artery bypass mortality rates in Ontario. A Canadian approach to quality assurance in cardiac surgery. Steering Committee of the Provincial Adult Cardiac Care Network of Ontario. Circulation (1996) 1.61

Primer on medical decision analysis: Part 4--Analyzing the model and interpreting the results. Med Decis Making (1997) 1.57

Appropriateness of primary total hip and knee replacements in regions of Ontario with high and low utilization rates. CMAJ (1996) 1.56

Use of vitamin B12 injections among elderly patients by primary care practitioners in Ontario. CMAJ (1999) 1.54

Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med (1997) 1.53

The burden of waiting for hip and knee replacements in Ontario. Ontario Hip and Knee Replacement Project Team. J Eval Clin Pract (1997) 1.53

Tentative guidelines for using clinical and economic evaluations revisited. CMAJ (1993) 1.53

Potential cost effectiveness of intravenous tissue plasminogen activator versus streptokinase for acute myocardial infarction. Can J Cardiol (1992) 1.52

Can the standard gamble be used to determine utilities for uncertain health states? An example using postoperative maintenance therapy in Crohn's disease. Med Decis Making (2000) 1.51

The relation of conjunctival pallor to the presence of anemia. J Gen Intern Med (1997) 1.50

Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma. Am J Hum Genet (1996) 1.49

Dealing with missing data in observational health care outcome analyses. J Clin Epidemiol (2000) 1.49

Clinical and population epidemiology: beyond sibling rivalry? J Clin Epidemiol (1990) 1.49

Evaluating the accuracy of nutritional assessment techniques applied to hospitalized patients: methodology and comparisons. JPEN J Parenter Enteral Nutr (1984) 1.46

The Canadian National Breast Screening Study: opportunity for a rethink. CMAJ (1992) 1.45

The relationship between cardiac functional capacity and patients' symptom-specific utilities for angina: some findings and methodologic lessons. Med Decis Making (1996) 1.41

Should ERCP be routine after an episode of "idiopathic" pancreatitis? A cost-utility analysis. Gastrointest Endosc (1996) 1.41

Universal hepatitis B vaccination: the economics of prevention. CMAJ (1992) 1.40

The effectiveness of a regulatory strategy in containing hospital costs. The Ontario experience, 1967-1981. N Engl J Med (1983) 1.39

Primer on medical decision analysis: Part 5--Working with Markov processes. Med Decis Making (1997) 1.39

Trends in clinical and economic outcomes of coronary angioplasty from 1992 to 1995: a population-based analysis. Am Heart J (1999) 1.39

Management of asymptomatic chronic aortic regurgitation with left ventricular dysfunction: a decision analysis. J Gen Intern Med (1990) 1.39

Assessing the outcomes of coronary artery bypass graft surgery: how many risk factors are enough? Steering Committee of the Cardiac Care Network of Ontario. J Am Coll Cardiol (1997) 1.39

Medical abortion: what does the research tell us? CMAJ (1996) 1.38

In the queue for total joint replacement: patients' perspectives on waiting times. Ontario Hip and Knee Replacement Project Team. J Eval Clin Pract (1998) 1.37

Comparison of the appropriateness of coronary angiography and coronary artery bypass graft surgery between Canada and New York State. JAMA (1994) 1.35

Biology or bias: practice patterns and long-term outcomes for men and women with acute myocardial infarction. J Am Coll Cardiol (2002) 1.35

Regional variation in medical care. N Engl J Med (1995) 1.35

Health services research: reporting on studies using secondary data sources. CMAJ (1996) 1.35

Fifteen-year trends in risk severity and operative mortality in elderly patients undergoing coronary artery bypass graft surgery. Circulation (1998) 1.32

No impact from active dissemination of the Ottawa Ankle Rules: further evidence of the need for local implementation of practice guidelines. CMAJ (1999) 1.30

A comparison of a Bayesian vs. a frequentist method for profiling hospital performance. J Eval Clin Pract (2001) 1.29

Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch Gen Psychiatry (1996) 1.26

Postmenopausal estrogen replacement therapy and increased rates of cholecystectomy and appendectomy. CMAJ (2000) 1.25

When does mass screening for open neural tube defects in low-risk pregnancies result in cost savings? CMAJ (1987) 1.25

A mass media programme to prevent smoking among adolescents: costs and cost effectiveness. Tob Control (1997) 1.24

Prescribing propensity: influence of life-expectancy gains and drug costs. J Gen Intern Med (1994) 1.24

Epidemic of the acquired immunodeficiency syndrome: a need for economic and social planning. Ann Intern Med (1983) 1.24

Self-perceived health status of women three to five years after the diagnosis of gestational diabetes: a survey of cases and matched controls. Am J Obstet Gynecol (1998) 1.24

Preoperative cardiac risk assessment for patients having peripheral vascular surgery. Ann Intern Med (1992) 1.23

Better care and better outcomes: the continuing challenge. JAMA (1998) 1.23

The need for acute, subacute and nonacute care at 105 general hospital sites in Ontario. Joint Policy and Planning Committee Non-Acute Hospitalization Project Working Group. CMAJ (1998) 1.23